“…Although it is important to acknowledge such exceptional cases, it also is important to avoid placing too much weight on unconfirmed and isolated reports, A B Figure 5 Correlations between residual enzyme activity and clinical severity in patient cells. Panel A is a box-whisker plot showing residual activities for Hprt as measured by the intact fibroblast assay for 56 patients previously reported (Itiaba et al, 1978;Bakay et al, 1979;Gottlieb et al, 1982;Warzok et al, 1982;Fattal et al, 1984;Lorentz et al, 1984;Mitchell and McInnes, 1984;Hersh et al, 1986;Tarle et al, 1991;Gilbert et al, 1992;Sege-Peterson et al, 1992;Jenkins et al, 1994;Erhard et al, 1997;Puig et al, 2001;Zoref-Shani et al, 2003Cherian and Crompton, 2005;Cossu et al, 2006;Jinnah et al, 2010;Sarafoglou et al, 2010;Torres et al, 2010). Panel B is a box-whisker plot showing residual activities for Hprt as measured by the intact erythrocyte assay for 54 patients previously reported (Shnier et al, 1972;Ludman et al, 1992;Sege-Peterson et al, 1992;Davidson et al, 1994;Willers et al, 1999;Puig et al, 2001;Augoustides-Savvopoulou et al, 2002;Bertelli et al, 2004;Kassimatis et al, 2005;Cossu et al, 2006;Garcia et al, 2008;de Gemmis et al, 2010;Corrigan et al, 2011).…”